pfizer news - Search News

Pfizer, Starboard Value

What activist hedge fund Starboard wants from Pfizer

Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO Jeff Smith.

Wall Street Journal · 1d

Starboard Chief Criticizes Pfizer’s R&D Investments

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its research and development investments, including investments done both internally and through mergers and acquisitions.

Barron's on MSN · 1d

Starboard Makes Its Case to Shake-Up Pfizer and Kenvue

Starboard has a $1 billion stake in Pfizer and an unknown but "sizable" stake in Kenvue, according to earlier media reports.

RSV, Pfizer

Reuters on MSN · 1d

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease.

BioPharma Dive · 9h

Pfizer’s RSV vaccine cleared by FDA for use in some younger adults

Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people eligible for vaccination with the shot.

The Wall Street Journal on MSN · 1d

Pfizer Receives FDA Approval for RSV Vaccine

Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at increased risk. It is the first RSV vaccine indicated for adults younger than 50,

Starboard Value CEO says Pfizer's board should hold management accountable

Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold ...

4hon MSN

CDC Panel Favors Wider Use of Pfizer, Merck Pneumococcal Shots

A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and ...

FiercePharma1d

UPDATED: Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

10hon MSN

Promise Bio exits stealth backed by Pfizer and AstraZeneca

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune ...

Commercial Observer9h

Metro Loft and David Werner Secure Full Control of Former Pfizer HQ

Earlier this year, the joint venture between Metro and Werner secured $75 million in acquisition financing to develop the ...

FiercePharma3h

In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines

With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...

McKnight's Long-Term Care News1d

FDA OKs Pfizer’s RSV vaccine for some adults under 60

On Tuesday, the US Food and Drug Administration (FDA) approved Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, for people 18 to 59 who are more vulnerable to the virus. Pfizer’s ...

More Pfizer layoffs hit North Carolina

Months after disclosing significant layoffs across its North Carolina operations, Pfizer (NYSE: PFE) plans to eliminate more ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Pfizer, Starboard Value

RSV, Pfizer

Related topics